1. |
K. Kato, M. Yamamoto, and Y. Ikada. Ultrastructure of the interface between cultured osteoblasts and polymer substrates carrying organophosphate graft chains, Bioceramics 9, T. Kokubo ed., Elsevier Science LTD, Oxford, (1996), 383-386.
|
2. |
M. Yamamoto, K. Kato, and Y. Ikada. Effect of the structure of bone morphogenetic protein carriers on ectopic bone regeneration, Tissue Engineering, 2, 4, (1996), 315-326.
|
3. |
M. Yamamoto, K. Kato, and Y. Ikada. Ultrastructure of the interface between cultured osteoblasts and surface-modified polymer substrates. Journal of Biomedical Materials Research, 37, 1, (1997), 29-36.
|
4. |
L. Hong, Y. Tabata, M. Yamamoto, S. Miyamoto, K. Yamada, N. Hashimoto, and Y. Ikada. Comparison of bone regeneration by bone morphogenetic protein incorporated in biodegradable hydrogel and in solution. Journal of Biomaterials Science, Polymer Edition, 9, 9, (1998), 1001-1014.
|
5. |
Y. Tabata, M. Yamamoto, and Y. Ikada. Biodegradable hydrogels for bone regeneration through growth factor release. Pure and Applied Chemistry, 70, 6, (1998), 1277-1282.
|
6. |
M. Yamamoto, Y. Tabata, and Y. Ikada. Ectopic bone formation induced by biodegradable hydrogels incorporating bone morphogenetic protein. Journal of Biomaterials Science, Polymer Edition, 9, 5, (1998), 439-458.
|
7. |
Y. Tabata, M. Yamamoto, and Y. Ikada. Comparison of release profiles of various growth factors from biodegradable carriers. Materials Research Society Symposium Proceedings, 530, R. C. Thomson, D. J. Mooney, K. E. Healy, Y. Ikada, and A. G. Mikos eds., Material Research Society, Pennsylvania, (1998), 13-18.
|
8. |
山本雅哉, 田畑泰彦, 筏 義人. ポリイオンコンプレックスを利用したヒドロゲルからの種々の細胞増殖因子の徐放化. Drug Delivery System, 14, 6, (1999), 506-510.
|
9. |
Y. Tabata, M. Miyao, M. Yamamoto, and Y. Ikada. Vascularization
into porous sponge by sustained release of basic fibroblast growth factor. Journal of Biomaterials Science, Polymer Edition, 10, 9,
(1999), 957-968.
|
10. |
M. Yamamoto, Y. Tabata, and Y. Ikada. Growth factor release from
gelatin hydrogel for Tissue Engineering. Journal of Bioactive Compatible Polymers, 14, 6, (1999),
474-489.
|
11. |
洪 流, 田畑泰彦, 山本雅哉, 宮本 享, 橋本信夫, 筏 義人. TGF-β1含有吸収性ゼラチンハイドロゲルの頭蓋骨再生能. Drug Delivery System, 14, 1, (1999), 43-50.
|
12. |
山本雅哉, 田畑泰彦, 筏 義人. 組織再生のための細胞成長因子のゼラチンヒドロゲルからの徐放, 生体材料, 18, 4, (2000), 194-200.
|
13. |
M. Yamamoto, Y. Tabata, L. Hong, S. Miyamoto, N. Hashimoto, and
Y. Ikada. Bone regeneration by transforming growth factor β1 released from
a biodegradable hydrogel. Journal of Controlled Release, 64
, 1-3, (2000), 133-142.
|
14. |
L. Hong, Y. Tabata, S. Miyamoto, M. Yamamoto, K. Yamada, N.
Hashimoto, and Y. Ikada. Bone regeneration at rabbit skull defects treated
with transforming growth factor-β1 incorporated into hydrogels with
different levels of biodegradability. Journal of Neurosurgery, 92, 2, (2000), 315-325.
|
15. |
M. Yamamoto, Y. Tabata, H. Kawasaki, and Y. Ikada. Promotion of
fibrovascular tissue ingrowth into porous sponges by basic fibroblast
growth factor. Journal of Materials Science: Materials in Medicine
, 11, 4, (2000), 213-218.
|
16. |
K. Kato, Y. Kikumura, M. Yamamoto, N. Tomita, S. Yamada, and Y.
Ikada. Collagen immobilization onto the surface of artificial hair for
improving the tissue adhesion. Journal of Adhesion Science and Technology, 14, 5, (2000),
635-650.
|
17. |
M. Yamamoto, Y. Ikada, and Y. Tabata. Controlled release of
growth factors based on biodegradation of gelatin hydrogel. Journal of Biomaterials Science, Polymer Edition, 12, 1,
(2001), 77-88.
|
18. |
H. Ueda, L. Hong, M. Yamamoto, K. Shigeno, M. Inoue, T. Toba, M.
Yoshitani, T. Nakamura, Y. Tabata, and Y. Shimizu. Use of collagen sponge
incorporating transforming growth factor-β1 to promote bone repair in skull
defects in rabbits. Biomaterials, 23, 4, (2001), 1003-1010.
|
19. |
Y. Sakakibara, K. Nishimura, K. Tambara, M. Yamamoto, F. Lu, Y.
Tabata, and M. Komeda. Prevascularization with gelatin microspheres
containing basic fibroblast growth factor enhances the benefits of
cardiomyocyte transplantation. The Journal of Thoracic and Cardiovascular Surgery, 124, 1,
(2002), 50-56.
|
20. |
T. Okamoto, Y. Yamamoto, M. Gotoh, D. Liu, M. Kihara, K. Kameyama, E.
Hayashi, K. Nakamura, A. Yamauchi, C.-L. Huang, H. Yokomise, M. Yamamoto, T. Nakamura, Y. Shimizu, and Y. Tabata. Cartilage
regeneration using slow release of bone morphogenetic protein-2 from a
gelatin sponge to treat experimental canine tracheomalacia: a preliminary
report. ASAIO Journal, 49, 1, (2003), 63-69.
|
21. |
M. Yamamoto, Y. Sakakibara, K. Nishimura, M. Komeda, and Y.
Tabata. Improved therapeutic efficacy in cardiomyocyte transplantation for
myocardial infarction with release system of basic fibroblast growth
factor. Artificial Organs, 27, 2, (2003), 181-198.
|
22. |
H. Ueda, T. Nakamura, M. Yamamoto, N. Nagata, S. Fukuda, Y.
Tabata, and Y. Shimizu. Repairing of rabbit skull defect by
dehydrothermally crosslinked collagen sponges incorporating transforming
growth factor β1. Journal of Controlled Release., 88, 1,
(2003), 55-64.
|
23. |
Y. Sakakibara, K. Tambara, G. Sakaguchi, F. Lu, M. Yamamoto, K.
Nishimura, Y. Tabata, and M. Komeda. Toward surgical angiogenesis using
slow-released basic fibroblast growth factor. European Journal of Cardio-Thoracic Surgery, 24, 1, (2003),
105-112.
|
24. |
M. Yamamoto, Y. Takahashi, and Y. Tabata. Controlled release by
biodegradable hydrogels enhances the ectopic bone formation of bone
morphogenetic protein. Biomaterials, 24, 24, (2003),
4375-4383.
|
25. |
Y. Yamamoto, T. Okamoto, M. Goto, H. Yokomise, M. Yamamoto, and
Y. Tabata. Experimental study of bone morphogenetic protein-2 slow release
from an artificial trachea made of biodegradable materials: evaluation of
stenting time. ASAIO Journal, 49, 5, (2003), 533-536.
|
26. |
中野貴由, 土田裕基, 石本卓也, 藤谷 渉, 馬越佑吉, 出口博史, 山本 融, 野口真一, 山本雅哉, 川上 理,
田畑泰彦, 山本敏男. 生体硬組織への結晶学的アプローチ -微小領域X線回折法ならびにSpring-8放射光施設によって-. Boundary, 19, 9, (2003), 16-20.
|
27. |
高松聖仁, 中塚洋直, 今井祐記, 越宗 勝, 金城養典, 榎本 誠, 高岡邦夫, 田畑泰彦, 山本雅哉, 筏 義人.
生体吸収性ポリマーチューブによるbFGF Drug Delivery Systemの末梢神経再生への応用. 移植, 39, 3, (2004), 353.
|
28. |
H. Takita, J. W.M. Vehof, J. A. Jansen, M. Yamamoto, Y. Tabata,
M. Tamura, and Y. Kuboki. Carrier dependent cell differentiation of bone
morphogenetic protein-2 induced osteogenesis and chondrogenesis during the
early implantation stage in rats. Journal of Biomedical Materials Research Part A, 71, 1,
(2004), 181-189.
|
29. |
A. Kanematsu, A. Marui, S. Yamamoto, M. Ozeki, Y. Hirano, M. Yamamoto, O. Ogawa, M. Komeda, and Y. Tabata. Type I collagen can
function as a reservoir of basic fibroblast growth factor. Journal of Controlled Release, 99, 2, (2004), 281-292.
|
30. |
T. Ishimoto, T. Nakano, Y. Umakoshi, M. Yamamoto, and Y. Tabata.
Effects of applied stress on preferential alignment of biological apatite
in rabbit forelimb bones. Phosphorus Research Bulletin, 17,
(2004), 77-82.
|
31. |
M. Yamamoto, Y. Takahashi, and Y. Tabata. Bone induction by
controlled release of BMP-2 from a biodegradable hydrogel in various animal
species -From mouse to non-human primate-. Key Engineering Materials, 288-289, (2005), 253-256.
|
32. |
Y. Takahashi, M. Yamamoto, and Y. Tabata. Osteogenic
differentiation of mesenchymal stem cells in biodegradable sponges composed
of gelatin and β-tricalcium phosphate. Biomaterials, 26,
17, (2005), 3587-3596.
|
33. |
Y. Takahashi, M. Yamamoto, and Y. Tabata. Enhanced
osteoinduction by controlled release of bone morphogenetic protein-2 from
biodegradable sponges composed of gelatin and b-tricalcium phosphate, Biomaterials, 26, 23, (2005), 4856-4865.
|
34. |
G. Sakaguchi, K. Tambara, Y. Sakakibara, M. Ozeki, M. Yamamoto,
G. Premaratne, X. Lin, K. Hasegawa, Y. Tabata, K. Nishimura, and M. Komeda.
Control-released hepatocyte growth factor prevents the progression of heart
failure in stroke-prone spontaneously hypertensive rats. The Annals of Thoracic Surgery, 79, 5, (2005), 1627-1634.
|
35. |
M. Yamamoto, Y. Takahashi, A. Hokugo, and Y. Tabata. Enhanced
osteoinduction by biodegradable gelatin-b-tricalcium phosphate sponge
capable for bone morphogenetic protein release. Journal of Hard Tissue Biology, 14, 2, (2005), 286-287.
|
36. |
A. Marui, A. Kanematsu, K. Yamahara, K. Doi, T. Kushibiki, M. Yamamoto, H. Itoh, T. Ikeda, Y. Tabata, and M. Komeda.
Simultaneous application of basic fibroblast growth factor and hepatocyte
growth factor to enhance the blood vessels formation. Journal of Vascular Surgery, 41, 1, (2005), 82-90.
|
37. |
Y. Takahashi, M. Yamamoto, and Y. Tabata. Design of an
osteoinductive biodegradable cell scaffold based on controlled release
technology of bone morphogenetic protein. Israel Journal of Chemistry, 45, 4, (2005), 465-475.
|
38. |
K. Tambara, G. U. Premaratne, G. Sakaguchi, N. Kanemitsu, X. Lin, H.
Nakajima, Y. Sakakibara, Y. Kimura, M. Yamamoto, Y. Tabata, T.
Ikeda, and M. Komeda. Administration of control-released hepatocyte growth
factor enhances the efficacy of skeletal myoblast transplantation in rat
infarcted hearts by greatly increasing both quantity and quality of the
graft. Circulation, 112, 9 Supplement, (2005), I129-I134.
|
39. |
J. Tazaki, T. Akazawa, M. Murata, M. Yamamoto, Y. Tabata, R.
Yoshimoto, and M. Arisue. BMP-2 dose-response and release studies in
functionally graded HAp. Archives of BioCeramics Research, 5,
(2005), 182-185.
|
40. |
Y. Takahashi, M. Yamamoto, and Y. Tabata. Enhanced bone
regeneration at a segmental bone defect by controlled release of bone
morphogenetic protein-2 from a biodegradable hydrogel. Tissue Engineering, 12, 5, (2006), 1305-1311.
|
41. |
H. Hosseinkhani, M. Yamamoto, Y. Inatsugu, Y. Hiraoka, S. Inoue,
H. Shimokawa, and Y. Tabata. Enhanced ectopic bone formation using a
combination of plasmid DNA impregnation into 3-D scaffold and bioreactor
perfusion culture. Biomaterials, 27, 8, (2006), 1387-1398.
|
42. |
T. Nakano, T. Ishimoto, J.-W. Lee, Y. Umakoshi, M. Yamamoto, Y.
Tabata, A. Kobayashi, H. Iwaki, K. Takaoka, M. Kawai, and T. Yamamoto.
Crystallographic approach to regenerated and pathological hard tissues. Materials Science Forum, 512, (2006), 255-260.
|
43. |
T. Ishimoto, T. Nakano, Y. Umakoshi, M. Yamamoto, and Y. Tabata.
Role of stress distribution on healing process of preferential alignment of
biological apatite in long bones. Materials Science Forum, 512, (2006), 261-264.
|
44. |
J.-W. Lee, T. Nakano, S. Toyosawa, N. Ijuhin, Y. Tabata, M. Yamamoto, and Y. Umakoshi. Role of osteoclast in preferential
alignment of biological apatite (BAp) in long bones. Materials Science Forum, 512, (2006), 265-268.
|
45. |
H. Igai, S.S. Chang, M. Gotoh, Y. Yamamoto, N. Misaki, T. Okamoto, M. Yamamoto, Y. Tabata, and H. Yokomise. Regeneration of canine
tracheal cartilage by slow release of basic fibroblast growth factor from
gelatin sponge. ASAIO Journal, 52, 1, (2006), 86-91.
|
46. |
J. Jo, M. Yamamoto, K. Matsumoto, T. Nakamura, and Y. Tabata.
Liver targeting of plasmid DNA with a cationized pullulan for tumor
suppression. Journal of Nanoscience and Nanotechnology, 6,
9-10, (2006), 2853-2859.
|
47. |
I. Kanatani, T. Ikai, A. Okazaki, J. Jo, M. Yamamoto, M.
Imamura, A. Kanematsu, S. Yamamoto, N. Ito, O. Ogawa, and Y. Tabata.
Efficient gene transfer by pullulan-spermine occurs through both clathrin-
and raft/caveolae-dependent mechanisms. Journal of Controlled Release., 116, 1, (2006), 75-82.
|
48. |
M. Yamamoto and Y. Tabata. Tissue Engineering by modulated gene
delivery. Advanced Drug Delivery Reviews, 58, (2006),
535-554.
|
49. |
丸井 晃, 田畑泰彦, 福島雅典, 北 徹, 中尾一和, 木村 剛, 伊藤 裕, 松井茂之, 長谷川浩二, 堀内久徳, 原田昌樹, 山本雅哉, 小島伸介, 仁科 健, 池田 義, 米田正始.
bFGF徐放による「時間的,空間的」局所血管新生 -安全性,低侵襲性への新たなる試み-. Cardiovascular Med-Surg, 8, 2, (2006), 83-87.
|
50. |
望月祐一, 朝村真一, 草田朗子, 森 廣政, 松永吉真, 山本雅哉, 田畑泰彦, 磯貝典孝.
BMP-2含浸ゼラチンハイドロゲルシートを用いた骨再生 ―イヌ眼窩床骨折モデルへの応用―. 再生医療, 6, 1, (2007), 20-26.
|
51. |
城 潤一郎, 三島史人, 武田真一, 山本雅哉, 村垣善浩, 伊関 洋, 佐保典英, 窪田 純, 佐々木 明, 西嶋茂宏,
田畑泰彦. 深部治療に対応したナノ磁性体を応用した次世代DDS型治療システム, Drug Delivery System, 22, 5, (2007), 558-568.
|
52. |
M. Yamamoto, K. Yanase, and Y. Tabata. Fabrication of
three-dimensional cell scaffolds with spatial gradients of biomolecules. Inflammation and Regeneration, 27, (2007), 102-106.
|
53. |
M. Murata, T. Akazawa, T. Sasaki, K. Ito, J. Tazaki, M. Yamamoto
, Y. Tabata, and M. Arisue. Blood Permeability of a Novel Ceramic Scaffold
for BMP-2.
Journal of Biomedical Materials Research Part B: Applied Biomaterials
, 81, 2, (2007), 469-475.
|
54. |
Y. Takahashi, M. Yamamoto, K. Yamada, O. Kawakami, and Y.
Tabata. Skull bone regeneration in non-human primates by controlled release
of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Engineering, 13, 2, (2007), 293-300.
|
55. |
J. Liu, S. Ohta, A. Sonoda, M. Yamada, M. Yamamoto, N. Nitta, K.
Murata, and Y. Tabata. Preparation of PEG-conjugated fullerene containing
Gd3+ ions for photodynamic therapy. Journal of Controlled Release, 117, 1, (2007), 104-110.
|
56. |
J. Jo, T. Ikai, A. Okazaki, K. Nagane, M. Yamamoto, Y. Hirano,
and Y. Tabata. Expression profile of plasmid DNA by spermine derivatives of
pullulan with different molecular weights . Journal of Biomaterials Science, Polymer Edition, 18, 7,
(2007), 883-899.
|
57. |
J. Jo, T. Ikai, A. Okazaki, K. Nagane, M. Yamamoto, Y. Hirano,
and Y. Tabata. Expression profile of plasmid DNA by spermine derivatives of
pullulan with different extents of spermine introduced. Journal of Controlled Release, 118, 3, (2007), 389-398.
|
58. |
H. Igai, Y. Yamamoto, S.S. Chang, M. Yamamoto, Y. Tabata, and H.
Yokomise. Tracheal cartilage regeneration by slow release of basic
fibroblast growth factor from a gelatin sponge. The Journal of Thoracic and Cardiovascular Surgery, 134, 1,
(2007), 170-175.
|
59. |
A. Marui, Y. Tabata, S. Kojima, M. Yamamoto, K. Tambara, T.
Nishina, Y. Saji, K. Inui, T. Hashida, S. Yokoyama, R. Onodera, T. Ikeda,
M. Fukushima, and M. Komeda. A novel approach to therapeutic angiogenesis
for patients with critical limb ischemia by sustained release of basic
fibroblast growth factor using biodegradable gelatin hydrogel: an initial
report of the phase I-IIa study. Circulation Journal, 71, 8,
(2007), 1181-1186.
|
60. |
T. Ishimoto, T. Nakano, Y. Umakoshi, M. Yamamoto, and Y. Tabata.
Change in Material and Structural Parameters of Bone Mechanical Function
during Long-Bone Regeneration. Materials Science Forum, 561-565, (2007), 1451-1454.
|
61. |
J. Tazaki, T. Akazawa, M. Murata, M. Yamamoto, Y. Tabata, J.
Hino, M. Arisue, and T. Shibata. Comparison of HAp and β-TCP in BMP-2
Dose-response and Release Study. Key Engineering Materials, 361-363, (2008), 1033-1036.
|
62. |
Z. S. Patel, H. Ueda, M. Yamamoto, Y. Tabata, and A. G. Mikos.
In vitro and in vivo release of vascular endothelial growth factor from
gelatin microparticles and biodegradable composite scaffolds. Pharmaceutical Research, 25, 10, (2008), 2370-2378.
|
63. |
Z. S. Patel, M. Yamamoto, H. Ueda, Y. Tabata, and A. G. Mikos.
Biodegradable gelatin microparticles as delivery systems for the controlled
release of bone morphogenetic protein-2. Acta Biomaterialia, 4, 5, (2008), 1126-1138.
|
64. |
H. Igai, S. S. Chang, M. Gotoh, Y. Yamamoto, M. Yamamoto, Y.
Tabata, and H. Yokomise. Tracheal cartilage regeneration and new bone
formation by slow release of bone morphogenetic protein (BMP)-2. ASAIO Journal, 54, 1, (2008), 104-108.
|
65. |
S. Nishijima, S. Takeda, F. Mishima, Y. Tabata, M. Yamamoto, J.
Jo, H. Iseki, Y. Muragaki, A. Sasaki, K. Jun, and N. Saho. A study of
magnetic drug delivery system using bulk high temperature superconducting
magnet. IEEE Transaction on Applied Superconductivity, 18,
2, (2008), 874-877.
|
66. |
N. Nishishita, J. Jo, M. Yamamoto, Y. Tabata, and Y. Hirano. The
gene transfection using cell attachment peptides for gene therapy. Peptide Science, 2007, (2008), 443-446.
|
67. |
G. Matsumoto, Y. Omi, E. Kubota, S. Ozono, H. Tsuzuki, Y. Kinoshita, M. Yamamoto, and Y. Tabata. Enhanced regeneration of critical bone
defects using a biodegradable gelatin sponge and β-tricalcium phosphate
with bone morphogenetic protein-2. Journal of Biomaterials Applications, 24, 4, (2009),
327-342.
|
68. |
X. Lin, K. Tambara, M. Fu, M. Yamamoto, G.U. Premaratne, Y.
Sakakibara, A. Marui, T. Ikeda, M. Komeda, and Y. Tabata. Controlled
Release of Matrix Metalloproteinase 1 with or without Skeletal Myoblasts
Transplantion Improves Cardiac Function of Rat Hearts with Chronic
Myocardial Infarction. Tissue Engineering Part A, 15, 9,
(2009), 2699-2706.
|
69. |
H. Igai, S. S. Chang, M. Gotoh, Y. Yamamoto, M. Yamamoto, Y.
Tabata, and H. Yokomise. Widespread and Early Tracheal Cartilage
Regeneration by Synchronous Slow Release of b-FGF and BMP-2. ASAIO Journal, 55, 3, (2009), 266-270.
|
70. |
J.Tazaki, M. Murata, T. Akazawa, M. Yamamoto, K. Ito, M. Arisue,
T. Shibata, and Y. Tabata. BMP-2 release and dose-response studies in
hydroxyapatite and beta-tricalcium phosphate. Bio-Medical Materials and Engineering, 19, 2-3, (2009), 141-146.
|
71. |
X. Lin, H. Jo, T. M. Ishii, M. Fujita, M. Fu, K. Tambara, M. Yamamoto, Y. Tabata, M.Komeda, and S. Matsuoka. Controlled
release of matrix metalloproteinase-1 plasmid DNA prevents left ventricular
remodeling in chronic myocardial infarction of rats. Circulation Journal, 73, 12, (2009), 2315-2321.
|
72. |
M. Komeda, A. Marui, K. Tambara, M. Yamamoto, Y. Saji, T.
Nishina, and Y. Tabata. Biologic anastomosis: the first case of biologic
coronary bypass surgery. The Journal of Thoracic and Cardiovascular Surgery, 138, 3,
(2009), 775-777.
|
73. |
H. Komobuchi, N. Hato, M. Teraoka, H. Wakisaka, H. Takahashi, K. Gyo,
Y. Tabata, and M. Yamamoto. Basic fibroblast growth factor combined
with biodegradable hydrogel promotes healing of facial nerve after
compression injury: an experimental study. Acta Oto-Laryngologica,
130, 1, (2009), 173-178, 2009.
|
74. |
M. Yamamoto, D. James, H. Li, J. Butler, S. Rafii, and S.Y.
Rabbany. Generation of Stable co-cultures of vascular cells in a honeycomb
alginate scaffold. Tissue Engineering Part A, 16, 1, (2010),
299-308.
|
75. |
J. Jo, A. Okazaki, K. Nagane, M. Yamamoto, and Y. Tabata.
Preparation of cationized polysaccharides as gene transfection carrier for
bone marrow-derived mesenchymal stem cells. Journal of Biomaterials Science, Polymer Edition, 21, 2, (2010),
185-204.
|
76. |
J. Jo, K. Nagane, M. Yamamoto, and Y. Tabata. Effect of amine
type on the expression of plasmid DNA by cationized dextran. Journal of Biomaterials Science, Polymer Edition, 21, 2, (2010),
225-236.
|
77. |
M. Yamamoto, K. Yanase, and Y. Tabata. Generation of Type I
Collagen Gradient in Polyacrylamide Hydrogels by a Simple
Diffusion-Controlled Hydrolysis of Amide Groups. Materials, 3, 4,
(2010), 2393-2404.
|
78. |
S.Y. Rabbany, J. Pastore, M. Yamamoto, T. Miller, S. Rafii, R.
Aras, and M. Penn. Continuous delivery of stromal cell-derived factor-1
from alginate scaffolds accelerates wound healing. Cell Transplantation, 19, 4, (2010), 399-408.
|
79. |
S. Asamura, Y. Mochizuki, M. Yamamoto, Y. Tabata, and N. Isogai.
Bone regeneration using a BMP-2-saturated slow-release gelatin hydrogel
sheet: evaluation in a canine orbital floor fracture model. Annals of Plastic Surgery, 64, 4, (2010), 496-502.
|
80. |
H. Kohara, S. Tajima, M. Yamamoto, and Y. Tabata. Angiogenesis
induced by controlled release of neuropeptide substance P. Biomaterials, 31, 33, (2010), 8617-8625.
|
81. |
S.C. Leeuwenburgh, J. Jo, H. Wang, M. Yamamoto, J.A. Jansen, and
Y. Tabata. Mineralization, biodegradation, and drug release behavior of
gelatin/apatite composite microspheres for bone regeneration. Biomacromolecules, 11, 10, (2010), 2653-2659.
|
82. |
T. Nakagawa, T. Sakamoto, H. Hiraumi, Y.S. Kikkawa, N. Yamamoto, K.
Hamaguchi, K. Ono, M. Yamamoto, Y. Tabata, S. Teramukai, S. Tanaka,
H. Tada, R. Onodera, A. Yonezawa, K. Inui, and J. Ito. Topical insulin-like
growth factor 1 treatment using gelatin hydrogels for
glucocorticoid-resistant sudden sensorineural hearing loss: a prospective
clinical trial. BMC Medicine, 8, (2010), 76.
|
83. |
J. Ratanavaraporn, S. Damrongsakkul, S. Kanokpanont, M. Yamamoto
, and Y. Tabata. Osteogenic Differentiation of Bone-Marrow-Derived Stem
Cells Cultured with Mixed Gelatin and Chitooligosaccharide Scaffolds. Journal of Biomaterials Science, Polymer Edition, 22, 8,
(2011), 1083-1098.
|
84. |
T. Ishimoto, T. Nakano, M. Yamamoto, and Y. Tabata.
Biomechanical evaluation of regenerating long bone by nanoindentation. Journal of Materials Science: Material in Medicine, 22, 4,
(2011), 969-976.
|
85. |
P.W. Henderson, S.P. Singh, D.D. Krijgh, M. Yamamoto, D.C.
Rafii, J.J. Sung, S. Rafii, S.Y. Rabbany, and J.A. Spector. Stromal-derived
factor-1 delivered via hydrogel drug-delivery vehicle accelerates wound
healing in vivo. Wound Repair and Regeneration, 19, 3,
(2011), 420-425.
|
86. |
H. Toda, M. Yamamoto, H. Kohara, and Y. Tabata.
Orientation-regulated immobilization of Jagged1 on glass substrates for ex
vivo proliferation of a bone marrow cell population containing
hematopoietic stem cells. Biomaterials, 32, 29, (2011),
6920-6928.
|
87. |
J. Liu, J. Jo, Y. Kawai, I. Aoki, C. Tanaka, M. Yamamoto, and Y.
Tabata. Preparation of polymer-based multimodal imaging agent to visualize
the process of bone regeneration. Journal of Controlled Release, 157, 3, (2012), 398-405.
|
88. |
K. Ohno, T. Akashi, Y. Tsujii, M. Yamamoto, and Y. Tabata. Blood
clearance and biodistribution of polymer brush-afforded silica particles
prepared by surface-initiated living radical polymerization. Biomacromolecules, 13, 3, (2012), 927-936.
|
89. |
J. Tazaki, M. Murata, T. Akazawa, M. Yamamoto, M. Arisue, T.
Shibata, H. Nagayasu, and Y. Tabata. The effect of partial
dissolution-precipitation treatment on calcium phosphate ceramics in the
release of BMP-2 and osteoinduction. Journal of Hard Tissue Biology, 21, 4, (2012), 459-468.
|
90. |
T. Ishimoto, T. Nakano, Y. Umakoshi, M. Yamamoto, and Y. Tabata.
Degree of biological apatite c-axis orientation rather than bone mineral
density controls mechanical function in bone regenerated using rBMP-2. Journal of Bone Mineral Research, 28, 5, (2013), 1170-1179.
|
91. |
Y. Iwasaki, K. Katayama, M. Yoshida, M. Yamamoto, and Y. Tabata.
Comparative physicochemical properties and cytotoxicity of polyphosphoester
ionomers with bisphosphonates. Journal of Biomaterials Science, Polymer Edition, 24, 7,
(2013), 882-895.
|
92. |
M. Yamamoto and Y. Tabata. Protein immobilization onto
biomaterial surfaces to control cell behaviors for tissue regeneration. International Journal of Tissue Regeneration, 4, (2013),
36-40.
|
93. |
M. Yamamoto, S. Rafii, and S. Y. Rabbany. Scaffold biomaterials
for nano-pathophysiology. Advanced Drug Delivery Reviews, 74, (2014), 104-114.
|
94. |
M. Kawago, T. Yoshimasu, Y. Tabata, M. Yamamoto, Y. Hirai, T.
Kinoshita, and Y. Okamura. Intrapleural administration of gelatin-embedded,
sustained-release basic fibroblast growth factor for the regeneration of
emphysematous lungs in rats. The Journal of Thoracic and Cardiovascular Surgery, 147, 5,
(2014), 1644-1649.
|
95. |
M. Yamamoto, Y. Ikada, and Y. Tabata. Ultrastructure of bone
tissue ectopically regenerated by biodegradable hydrogels incorporating
bone morphogenetic protein-2. Inflammation and Regeneration, 34, 1, (2014), 56-63.
|
96. |
M. Yamamoto, A. Hokugo, Y. Takahashi, T. Nakano, M. Hiraoka, and
Y. Tabata. Combination of BMP-2-releasing gelatin/β-TCP sponges with
autologous bone marrow for bone regeneration of X-ray-irradiated rabbit
ulnar defects. Biomaterials, 56, (2015), 18-25.
|
97. |
N. Morimoto, N, Kakudo, M. Matsui, M. Ogura, T. Hara, K. Suzuki, M. Yamamoto, Y. Tabata, and K. Kusumoto. Exploratory clinical trial
of combination wound therapy with a gelatin sheet and platelet-rich plasma
in patients with chronic skin ulcers: study protocol. BMJ Open, 5, 5, (2015), e007733.
|
98. |
M. Watanabe, H. Li, A.G. Kim, A. Weilerstein, A. Radu, M. Davey, S.
Loukogeorgakis, M.D. Sánchez, K. Sumita, N. Morimoto, M. Yamamoto,
Y. Tabata, A. W. Flake. Complete tissue coverage achieved by scaffold-based
Tissue Engineering in the fetal sheep model of Myelomeningocele. Biomaterials, 76, (2016), 133-143.
|
99. |
M. Kumagai, A. Marui, Y. Tabata, T. Takeda, M. Yamamoto, A.
Yonezawa, S. Tanaka, S. Yanagi, T. Ito-Ihara, T. Ikeda, T. Murayama, S.
Teramukai, T. Katsura, K. Matsubara, K. Kawakami, M. Yokode, A. Shimizu,
and R. Sakata. Safety and efficacy of sustained release of basic fibroblast
growth factor using gelatin hydrogel in patients with critical limb
ischemia. Heart Vessels, 31, 5, (2016), 713-721.
|
100. |
H. Toda, M. Yamamoto, H. Uyama, and Y. Tabata. Fabrication of
hydrogels with elasticity changed by alkaline phosphatase for stem cell
culture. Acta Biomaterialia, 29, (2016), 215-227.
|
101. |
N. Morimoto, N. Kakudo, T. Ogura, T. Hara, M. Matsui, M. Yamamoto, Y. Tabata, and K. Kusumoto. Easy-to-use preservation
and application of platelet-rich plasma in combination wound therapy with a
gelatin sheet and freeze-dried platelet-rich plasma: a case report. ePlasty, 16, (2016), 202-207.
|
102. |
Effect of hydrogel elasticity and ephrinB2-immobilized manner on Runx2
expression of human mesenchymal stem cells. H. Toda, M. Yamamoto, H.
Uyama, Y. Tabata. Acta Biomater., 58, (2017), 312-322.
|
103. |
Design of magnetic gene complexes as effective and serum resistant
gene delivery systems for mesenchymal stem cells. T. Y. Zhang, J. H. Wu, Q.
H. Xu, X. R. Wang, J. Lu, Y. Hu, J. Jo, M. Yamamoto, D. Ling, Y.
Tabata, J. Q. Gao. Int. J. Pharm., 520, (2017), 1-13.
|